-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- And Another Thing: Supporting Information Files at PLOS in Work In Progress
- An Advocate for the Amish at a Very Special Clinic in Work In Progress
- Jeffrey Sachs: On climate, more 'now' and 'how' is needed in Work In Progress
- Reptilian Sibling Rivalry in Work In Progress
- What do PLOS and Lady Gaga have in common? in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.